Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma
mycophenolate mofetil - Generic mfg.
Pathogenesis, Treatment Advances, and Renal Outcomes in Childhood-Onset Lupus Nephritis. (PubMed, Clin Pediatr (Phila)) - Feb 19, 2026 - "In ascertained renal failure, renal transplantation is implied to be the most favorable modality of renal replacement therapy in this specific patient group. This review aims to describe childhood-onset LN and provide an overview on the pathogenesis, therapeutic approaches, emerging therapies and present renal outcomes for this disease with the objective of recognizing the key features that might aid in reducing the risk of long-term CKD." 
Journal • Review • Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammation • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Pediatrics • Renal Disease • Systemic Lupus Erythematosus • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41709467
 
Aqsa Safdar
 
Feb 19, 2026
 
Prev Next